Ductal carcinoma in situ of the breast: Evaluation of main presentations on magnetic resonance imaging compared with findings on mammogram and histology.
暂无分享,去创建一个
G. Badan | C. A. Ferreira | Felipe Augusto Trocoli Ferreira | E. Fleury | M. Campos | D. Roveda | Sebastião Paito | B. Maragno | Gustavo Machado Badan | Décio Roveda | Sebastião Paito | Eduardo de Faria Castro Fleury | Bianca Maragno | Mario Sérgio Dantas do Amaral Campos | Carlos Alberto Pecci Ferreira | Mário Sérgio Dantas do Amaral Campos
[1] S. Edge,et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. , 1995, Radiology.
[2] Wendy B DeMartini,et al. BI‐RADS MRI Enhancement Characteristics of Ductal Carcinoma In Situ , 2007, The breast journal.
[3] S. Duffy,et al. Mammographic screening and "overdiagnosis". , 2011, Radiology.
[4] O Lucidarme,et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. , 1996, Journal of computer assisted tomography.
[5] W. P. Evans,et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. , 1996, Radiology.
[6] S. Swain,et al. Ductal carcinoma in situ, complexities and challenges. , 2004, Journal of the National Cancer Institute.
[7] M. Schnall,et al. MR imaging of ductal carcinoma in situ. , 1997, Radiology.
[8] L. Liberman,et al. Determination of the Presence and Extent of Pure Ductal Carcinoma in Situ by Mammography and Magnetic Resonance Imaging , 2005, The breast journal.
[9] G. Newstead. MR imaging of ductal carcinoma in situ. , 2010, Magnetic resonance imaging clinics of North America.
[10] C. Boetes,et al. False-negative MR imaging of malignant breast tumors , 1997, European Radiology.
[11] M D Schnall,et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. , 1995, Radiology.
[12] C. Lehman. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. , 2010, Journal of the National Cancer Institute. Monographs.
[13] K. Scheidhauer,et al. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Anthony J. Guidi,et al. Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast , 1997, Cancer.
[15] U. Fischer,et al. MR imaging of mammographically detected clustered microcalcifications: is there any value? , 1998, Radiology.
[16] J O Barentsz,et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. , 1995, Radiology.
[17] A. Abramson,et al. Ductal carcinoma in situ: mammographic findings and clinical implications. , 1989, Radiology.
[18] O Lucidarme,et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. , 1994, Radiology.
[19] W. Lawrence,et al. Intraductal "noninfiltrating" carcinoma of the breast. , 1976, Archives of surgery.
[20] K. Kerlikowske,et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.
[21] Simone Schrading,et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study , 2007, The Lancet.
[22] Min-Ying Su,et al. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? , 2010, Journal of oncology.
[23] L Duchateau,et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Thomas Beier,et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. , 2002, Radiology.
[25] L. Tabár,et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.
[26] L. Kalisher,et al. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. , 1995, Radiology.
[27] Karel G M Moons,et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. , 2008, Radiology.
[28] J.,et al. In situ and minimally invasive breast cancer : morphologic and kinetic features on contrast-enhanced MR imaging , 2022 .
[29] G. Badan,et al. Complete internal audit of a mammography service in a reference institution for breast imaging* , 2014, Radiologia brasileira.
[30] C. Kuhl. Why do purely intraductal cancers enhance on breast MR images? , 2009, Radiology.
[31] R. Gilles,et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. , 1995, Radiology.
[32] Rebecca S Lewis,et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.
[33] R. Schmidt,et al. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. , 2007, Radiology.